Back to Search
KATHERINE OAKLEY, M.D.
M.D.
General Practice Physician
NPI: 1083064935Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (8)
Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.
PMID 16001179·Cancer Chemother Pharmacol·2006
7-preclinical
Differential expression of COX-1 and COX-2 in the gastrointestinal tract of the rat.
PMID 15902967·Toxicol Pathol·2005
7-preclinical
Thyroid cancers express CD-40 and CD-40 ligand: cancers that express CD-40 ligand may have a greater risk of recurrence in young patients.
PMID 15753667·Thyroid·2005
8-other
BRAF mutations are uncommon in papillary thyroid cancer of young patients.
PMID 15876153·Thyroid·2005
8-other
Painful bone metastases: a prospective observational cohort study.
PMID 16295283·Palliat Med·2005
8-other
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
PMID 11284937·Clin Microbiol Infect·2001
4-observational
Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection.
PMID 10629017·J Antimicrob Chemother·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1601 MONTE VISTA AVE STE 190
CLAREMONT, CA 91711 - Phone
- (909) 865-9977
Quick Facts
- NPI
- 1083064935
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 8
Are you this provider?
Claim Your Profile